Cochrane · systematic review · CD014936
Smoking cessation for secondary prevention of cardiovascular disease
Wu, AD, Lindson, N, Hartmann-Boyce, J, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library
Tobacco AddictionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Smoking cessation compared to continuous smoking for prevention of secondary cardiovascular disease events
Population: people with coronary heart diease
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Death from cardiovascular disease at 19 months to 126 months Smoking cessation vs continuous smoking | HR 0.61 [0.49, 0.75] | 18 studies · 17982 participants | Moderate Downgraded: risk of bias, inconsistency |
Major adverse cardiovascular events (MACE) at 19 months to 110 months Smoking cessation vs continuous smoking | HR 0.57 [0.45, 0.71] | 15 studies · 20521 participants | Low Downgraded: risk of bias, inconsistency, publication bias |